AI-CVD vs Withings Scan Monitor
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your healthcare facility aims to proactively identify hidden cardiovascular and multisystem disease risks in patients who have already undergone CT scans for other indications. This platform is ideal for leveraging existing imaging data to perform opportunistic screening, such as coronary artery calcium scoring and cardiac chamber volumetry, without requiring additional patient visits, radiation, or workflow disruption.
View AI-CVD →Choose Withings Scan Monitor if…
Choose Withings Scan Monitor if you require a convenient, device-based solution for continuous personal health monitoring or remote patient monitoring programs. This platform is best suited for individuals or clinicians focused on regular, at-home tracking of vital metrics like ECG for AFib detection, heart rate, and body composition, seamlessly integrating health data into daily life via smart scales and smartwatches.
View Withings Scan Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-CVD | Withings Scan Monitor |
|---|---|---|
| Pricing | Unknown | Device purchase with optional subscription for enhanced features and clinical services. |
| Deployment | Unknown | Device-based (smart scale, smartwatch) with cloud synchronization and mobile application. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools demonstrate high usability for their respective target audiences. AI-CVD seamlessly integrates into existing clinical radiology workflows, minimizing disruption for healthcare professionals. Withings Scan Monitor offers intuitive, device-based monitoring for consumers, making health tracking part of daily life.
Clinical Value
AI-CVDAI-CVD offers broader clinical value by leveraging existing CT scans for opportunistic screening across a wider array of cardiovascular and multisystem diseases, including early detection of hidden risks like osteoporosis and liver steatosis, beyond just cardiac conditions. This comprehensive approach to extracting new insights from already acquired data provides significant potential for proactive patient management.
Pricing & Value
Withings Scan MonitorWithings Scan Monitor offers clear and transparent pricing, including device costs and optional subscription fees, making its value proposition easily understandable for consumers and potentially for healthcare providers implementing RPM programs. AI-CVD's 'contact for pricing' approach, while typical for enterprise solutions, lacks immediate transparency for direct comparison.
Enterprise Readiness
AI-CVDAI-CVD is explicitly designed as an enterprise-grade quantitative imaging platform that integrates directly into existing clinical CT scan workflows, offering a scalable solution for hospitals and imaging centers without workflow disruption. Its focus on leveraging existing infrastructure for opportunistic screening positions it strongly for large-scale clinical adoption.
Innovation
AI-CVDAI-CVD demonstrates a higher degree of innovation in the clinical AI space by uniquely leveraging already acquired CT scan data to opportunistically screen for a broad spectrum of hidden cardiovascular and multisystem diseases, significantly enhancing early detection without additional procedures or radiation. This approach maximizes the value of existing clinical resources.
Support & Docs
Withings Scan MonitorWithings provides comprehensive and easily accessible public-facing support resources, including detailed FAQs, troubleshooting guides, user manuals, email, and live chat options for its consumer-oriented devices. Information regarding HeartLung Corporation's AI-CVD support and documentation is not publicly available, which is common for B2B solutions but makes direct comparison difficult for this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | Withings Scan Monitor |
|---|---|---|
| Name | AI-CVD | Withings Scan Monitor |
| Company | HeartLung Corporation | Withings |
| Description | AI-CVDu00ae is an FDA-cleared, AI-powered quantitative imaging platform from HeartLung Corporation that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. | Withings Scan Monitor is an AI-powered tool integrated into smart scales and smartwatches, offering FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring. |
| Key Features | Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing | 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan), Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch), Heart rate measurement and irregular rhythm notifications, Blood oxygen saturation (SpO2) measurement (ScanWatch), Vascular Age assessment (Body Scan), Nerve Health Score (Electrodermal Activity) (Body Scan), Segmental body composition analysis (Body Scan), Automatic data synchronization via Wi-Fi and Bluetooth |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and Withings Scan Monitor.